BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25399667)

  • 1. Long-term outcomes of autologous stem cell transplantation for peripheral T-cell lymphomas across the Thames Valley (1997-2012).
    Sims MC; Newell K; Eyre TA; Hatton C; Collins GP
    Br J Haematol; 2015 May; 169(3):452-5. PubMed ID: 25399667
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation.
    Kahl C; Leithäuser M; Wolff D; Steiner B; Hartung G; Casper J; Freund M
    Ann Hematol; 2002 Nov; 81(11):646-50. PubMed ID: 12454703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remission.
    Mehta N; Maragulia JC; Moskowitz A; Hamlin PA; Lunning MA; Moskowitz CH; Zelenetz A; Matasar MJ; Sauter C; Goldberg J; Horwitz SM
    Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):664-70. PubMed ID: 24035712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.
    d'Amore F; Relander T; Lauritzsen GF; Jantunen E; Hagberg H; Anderson H; Holte H; Österborg A; Merup M; Brown P; Kuittinen O; Erlanson M; Østenstad B; Fagerli UM; Gadeberg OV; Sundström C; Delabie J; Ralfkiaer E; Vornanen M; Toldbod HE
    J Clin Oncol; 2012 Sep; 30(25):3093-9. PubMed ID: 22851556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of high-dose chemotherapy and autologous stem cell transplant for treatment-naΪve patients with peripheral T-cell lymphoma: a systematic review of the literature.
    Jethwa KD; Bishton MJ; Fox CP
    Br J Haematol; 2017 Aug; 178(3):476-479. PubMed ID: 27146257
    [No Abstract]   [Full Text] [Related]  

  • 6. [Successful therapy for enteropathy-associated peripheral T-cell lymphoma using high-dose polychemotherapy and autologous hematopoietic stem cell transplantation].
    Vorob'ev VI; Kravchenko SK; Kovrigina AM
    Ter Arkh; 2013; 85(7):79-83. PubMed ID: 24137952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose therapy and stem cell transplantation.
    Zinzani PL
    Semin Hematol; 2010 Apr; 47 Suppl 1():S15-7. PubMed ID: 20359581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
    Shustov A
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas.
    Blystad AK; Enblad G; Kvaløy S; Berglund A; Delabie J; Holte H; Carlson K; Kvalheim G; Bengtsson M; Hagberg H
    Bone Marrow Transplant; 2001 Apr; 27(7):711-6. PubMed ID: 11360110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.
    Gkotzamanidou M; Papadimitriou CA
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study.
    Reimer P; Rüdiger T; Geissinger E; Weissinger F; Nerl C; Schmitz N; Engert A; Einsele H; Müller-Hermelink HK; Wilhelm M
    J Clin Oncol; 2009 Jan; 27(1):106-13. PubMed ID: 19029417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma treated with bortezomib and high-dose CHOP-like chemotherapy followed by autologous peripheral stem cell transplantation.
    Otrock ZK; Hatoum HA; Salem ZM; Tawil A; Mahfouz RA; Zaatari GS; Bazarbachi A
    Ann Hematol; 2008 Dec; 87(12):1023-4. PubMed ID: 18587577
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of high-dose therapy in peripheral T-cell lymphomas.
    Reimer P; Rüdiger T; Wilhelm M
    Clin Lymphoma Myeloma; 2006 Mar; 6(5):373-9. PubMed ID: 16640812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter study of comparative outcomes of hematopoietic stem cell transplant for peripheral T cell lymphoma and natural killer/T-cell lymphoma.
    Hwang WY; Koh LP; Lim ST; Linn YC; Loh YS; Koh MB; Diong CP; Lee JJ; Zhang XH; Rajgor D; Gandhi M; Shah A; Goh YT
    Leuk Lymphoma; 2011 Jul; 52(7):1382-6. PubMed ID: 21599577
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience.
    Rodríguez J; Conde E; Gutiérrez A; Arranz R; Gandarillas M; Leon A; Ojanguren J; Sureda A; Carrera D; Bendandi M; Moraleda J; Ribera JM; Albo C; Morales A; García JC; Fernández P; Cañigral G; Bergua J; Caballero MD;
    Eur J Haematol; 2007 Apr; 78(4):290-6. PubMed ID: 17378891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of advanced peripheral T-cell lymphoma with an angiocentric growth pattern complicated with hemophagocytic syndrome by high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
    Sato T; Kogawa K; Iyama S; Kobayashi D; Sato Y; Kuribayashi K; Takada K; Hagiwara S; Oku T; Takahashi S; Matsunaga T; Takahashi M; Terui T; Kato J; Niitsu Y
    Ann Hematol; 2002 Dec; 81(12):739-43. PubMed ID: 12483373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey.
    Jantunen E; Wiklund T; Juvonen E; Putkonen M; Lehtinen T; Kuittinen O; Franssila K; Söderström KO; Leppä S; Elonen E; Remes K; Nousiainen T
    Bone Marrow Transplant; 2004 Feb; 33(4):405-10. PubMed ID: 14676776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.
    Kim MK; Kim S; Lee SS; Sym SJ; Lee DH; Jang S; Park CJ; Chi HS; Huh J; Suh C
    Ann Hematol; 2007 Jun; 86(6):435-42. PubMed ID: 17256144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial.
    Ahn JS; Yang DH; Jung SH; Chae YS; Sohn SK; Yhim HY; Kwak JY; Lee SR; Kim YK; Kim HJ; Lee JJ
    Ann Hematol; 2013 Jun; 92(6):789-97. PubMed ID: 23358616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current treatment of peripheral T-cell lymphoma.
    Horwitz SM; Coiffier B; Hsi ED; Pro B
    Clin Adv Hematol Oncol; 2011 Aug; 9(8 Suppl 16):1-15. PubMed ID: 22361915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.